Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
PLoS One ; 16(8): e0256638, 2021.
Article in English | MEDLINE | ID: covidwho-1372018

ABSTRACT

BACKGROUND: The COVID-19 pandemic has impacted surveillance activities for multiple pathogens. Since March 2020, there was a decline in the number of reports of norovirus and Campylobacter recorded by England's national laboratory surveillance system. The aim is to estimate and compare the impact of the COVID-19 pandemic on norovirus and Campylobacter surveillance data in England. METHODS: We utilised two quasi-experimental approaches based on a generalised linear model for sequential count data. The first approach estimates overall impact and the second approach focuses on the impact of specific elements of the pandemic response (COVID-19 diagnostic testing and control measures). The following time series (27, 2015-43, 2020) were used: weekly laboratory-confirmed norovirus and Campylobacter reports, air temperature, conducted Sars-CoV-2 tests and Index of COVID-19 control measures stringency. RESULTS: The period of Sars-CoV-2 emergence and subsequent sustained transmission was associated with persistent reductions in norovirus laboratory reports (p = 0.001), whereas the reductions were more pronounced during pandemic emergence and later recovered for Campylobacter (p = 0.075). The total estimated reduction was 47% - 79% for norovirus (12-43, 2020). The total reduction varied by time for Campylobacter, e.g. 19% - 33% in April, 1% - 7% in August. CONCLUSION: Laboratory reporting of norovirus was more adversely impacted than Campylobacter by the COVID-19 pandemic. This may be partially explained by a comparatively stronger effect of behavioural interventions on norovirus transmission and a relatively greater reduction in norovirus testing capacity. Our study underlines the differential impact a pandemic may have on surveillance of gastrointestinal infectious diseases.


Subject(s)
COVID-19/epidemiology , Caliciviridae Infections/diagnosis , Campylobacter Infections/diagnosis , Laboratories/statistics & numerical data , COVID-19/virology , COVID-19 Testing , Caliciviridae Infections/epidemiology , Caliciviridae Infections/virology , Campylobacter/isolation & purification , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , England/epidemiology , Humans , Norovirus/isolation & purification , Pandemics , SARS-CoV-2/isolation & purification
2.
Viruses ; 13(7)2021 07 13.
Article in English | MEDLINE | ID: covidwho-1314758

ABSTRACT

Human coronaviruses, including SARS-CoV-2, are known to spread mainly via close contact and respiratory droplets. However, other potential means of transmission may be present. Fomite-mediated transmission occurs when viruses are deposited onto a surface and then transfer to a subsequent individual. Surfaces can become contaminated directly from respiratory droplets or from a contaminated hand. Due to mask mandates in many countries around the world, the former is less likely. Hands can become contaminated if respiratory droplets are deposited on them (i.e., coughing or sneezing) or through contact with fecal material where human coronaviruses (HCoVs) can be shed. The focus of this paper is on whether human coronaviruses can transfer efficiently from contaminated hands to food or food contact surfaces. The surfaces chosen were: stainless steel, plastic, cucumber and apple. Transfer was first tested with cellular maintenance media and three viruses: two human coronaviruses, 229E and OC43, and murine norovirus-1, as a surrogate for human norovirus. There was no transfer for either of the human coronaviruses to any of the surfaces. Murine norovirus-1 did transfer to stainless steel, cucumber and apple, with transfer efficiencies of 9.19%, 5.95% and 0.329%, respectively. Human coronavirus OC43 transfer was then tested in the presence of fecal material, and transfer was observed for stainless steel (0.52%), cucumber (19.82%) and apple (15.51%) but not plastic. This study indicates that human coronaviruses do not transfer effectively from contaminated hands to contact surfaces without the presence of fecal material.


Subject(s)
COVID-19/transmission , Coronavirus Infections/transmission , Food Microbiology , SARS-CoV-2/physiology , COVID-19/virology , Cell Line , Common Cold/transmission , Coronavirus/isolation & purification , Coronavirus 229E, Human/isolation & purification , Coronavirus OC43, Human/isolation & purification , Equipment Contamination , Feces/virology , Fomites , Foodborne Diseases/virology , Humans , Norovirus/isolation & purification , Stainless Steel
3.
PLoS One ; 16(5): e0251872, 2021.
Article in English | MEDLINE | ID: covidwho-1234592

ABSTRACT

BACKGROUND: As the SARS-CoV-2 pandemic accelerates, the supply of personal protective equipment remains under strain. To combat shortages, re-use of surgical masks and filtering facepiece respirators has been recommended. Prior decontamination is paramount to the re-use of these typically single-use only items and, without compromising their integrity, must guarantee inactivation of SARS-CoV-2 and other contaminating pathogens. AIM: We provide information on the effect of time-dependent passive decontamination (infectivity loss over time during room temperature storage in a breathable bag) and evaluate inactivation of a SARS-CoV-2 surrogate and a non-enveloped model virus as well as mask and respirator integrity following active multiple-cycle vaporised hydrogen peroxide (VHP), ultraviolet germicidal irradiation (UVGI), and dry heat (DH) decontamination. METHODS: Masks and respirators, inoculated with infectious porcine respiratory coronavirus or murine norovirus, were submitted to passive decontamination or single or multiple active decontamination cycles; viruses were recovered from sample materials and viral titres were measured via TCID50 assay. In parallel, filtration efficiency tests and breathability tests were performed according to EN standard 14683 and NIOSH regulations. RESULTS AND DISCUSSION: Infectious porcine respiratory coronavirus and murine norovirus remained detectable on masks and respirators up to five and seven days of passive decontamination. Single and multiple cycles of VHP-, UVGI-, and DH were shown to not adversely affect bacterial filtration efficiency of masks. Single- and multiple UVGI did not adversely affect respirator filtration efficiency, while VHP and DH induced a decrease in filtration efficiency after one or three decontamination cycles. Multiple cycles of VHP-, UVGI-, and DH slightly decreased airflow resistance of masks but did not adversely affect respirator breathability. VHP and UVGI efficiently inactivated both viruses after five, DH after three, decontamination cycles, permitting demonstration of a loss of infectivity by more than three orders of magnitude. This multi-disciplinal approach provides important information on how often a given PPE item may be safely reused.


Subject(s)
COVID-19/metabolism , Decontamination/methods , Hydrogen Peroxide/pharmacology , Norovirus/drug effects , Personal Protective Equipment/supply & distribution , SARS-CoV-2/drug effects , Anti-Infective Agents/pharmacology , COVID-19/epidemiology , COVID-19/virology , Equipment Reuse , Hot Temperature , Humans , Masks/microbiology , Norovirus/isolation & purification , Pandemics , Personal Protective Equipment/microbiology , Respiratory Protective Devices/microbiology , SARS-CoV-2/isolation & purification , Ultraviolet Rays , Ultraviolet Therapy , Ventilators, Mechanical/microbiology , Volatilization
4.
Acta Med Acad ; 49(3): 278-280, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-1154750

ABSTRACT

Norovirus is a substantial burden on the U.S. We compared norovirus outbreaks before and during COVID-19. There were fewer norovirus outbreaks during COVID-19 compared to a similar time period in 2019 (326 versus 638, P<0.001). CONCLUSION: COVID-19 public health interventions may be considered to decrease the burden of norovirus. This demonstrates the ability of more restrictive interventions to decrease other outbreaks of known or emerging viruses.


Subject(s)
COVID-19 , Caliciviridae Infections , Communicable Disease Control , Norovirus/isolation & purification , COVID-19/epidemiology , COVID-19/prevention & control , Caliciviridae Infections/diagnosis , Caliciviridae Infections/epidemiology , Caliciviridae Infections/prevention & control , Communicable Disease Control/methods , Communicable Disease Control/organization & administration , Communicable Disease Control/statistics & numerical data , Disease Transmission, Infectious/prevention & control , Humans , Public Health/methods , Public Health/statistics & numerical data , SARS-CoV-2 , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL